-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613.O2.6 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Treatment of BCR:ABL+ and T Cell Diseases

Symposia: Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Combination therapy, Adult, Translational Research, Clinical Research, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Adverse Events, Study Population, Human, Measurable Residual Disease
Monday, December 9, 2024: 2:45 PM-4:15 PM
Marriott Grand Ballroom 2-4 (Marriott Marquis San Diego Marina)
Moderators:
Guru Subramanian Guru Murthy, MBBS, Medical College of Wisconsin and Anjali S. Advani, MD, Cleveland Clinic Taussig Cancer Institute
Disclosures:
Advani: MJH Life: Honoraria; Kite: Consultancy, Research Funding; Wolters Kluwer: Honoraria; Web MD: Honoraria; Emmes: Honoraria; PER: Honoraria; American Society of Hematology: Honoraria; Wiley: Honoraria; Pfizer: Other: Manuscript help, Research Funding; Glycomimetics: Research Funding; Springer: Honoraria; MD Education: Honoraria; Amgen: Research Funding; BEAM: Other: Research support, Research Funding; OBI: Research Funding; Incyte: Research Funding; Immunogen: Research Funding; Seattle Genetics: Research Funding; Macrogenics: Research Funding; Servier: Research Funding; Kura: Research Funding; Novartis: Consultancy.
2:45 PM

Sabina Chiaretti, MD, PhD1, Matteo Leoncin2*, Loredana Elia1*, Stefano Soddu3*, Alfonso Piciocchi3*, Mabel Matarazzo4*, Mariangela Di Trani4*, Maurizio Martelli, MD1*, Erika Borlenghi, MD5*, Marina Parisi6*, Valentina Mancini, MD7*, Caterina Alati, MD8*, Daniele G. Mattei, MD9, Maria Paola Martelli, MD, PhD10*, Prassede Salutari, MD11*, Patrizia Chiusolo, MD, PhD12*, Ernesta Audisio, MD13*, Mario Luppi, MD14*, Lara Pochintesta15*, Crescenza Pasciolla16*, Bianca Serio, MD17*, Barbara Scappini18*, Antonella Cucca19*, Martina Chiarucci20*, Massimiliano Bonifacio, MD21*, Nicola Fracchiolla22*, Silvia Imbergamo23*, Lucia Ammirati, MD24*, Federico Mosna25*, Patrizia Zappasodi26*, Sara Mastaglio, MD27*, Daniela Pietrasanta28*, Monica Bocchia, MD29*, Monia Lunghi30*, Elisabetta Todisco31*, Paola Fazi3*, Alessandro Rambaldi32 and Robin Foà, MD4*

1Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
2Azienda Ulss3 Serenissima,Hematology Unit, Ospedale dell'Angelo, Venezia, Italy
3GIMEMA Foundation, Rome, Italy
4Department of Translational and Precision Medicine, Division of Hematology, Sapienza University, Rome, Italy
5ASST Spedali Civili, Brescia, Department of Hematology, Brescia, Italy
6UO di Ematologia - Catania, Catania, Italy
7Department of Hematology and Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
8U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
9ASO S. Croce e Carle, Cuneo, Italy
10Department of Medicine and Surgery, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
11Department of Hematology, Ospedale Civile Spirito Santo, Pescara, Pescara, Italy
12UOC Ematologia e Trapianto Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Rome, Italy
13SC Ematologia 2, AOU Città della Salute e della Scienza, Turin, Italy
14Hematology Unit and Chair, Department of Medical and Surgical Sciences, Azienda Ospedaliera Universitaria di Modena, University of Modena and Reggio Emilia, Modena, Italy
15ASL DI PIACENZA, OSPEDALE "GUGLIELMO DA SALICETO", Piacenza, Italy
16Ematologia, Istituto Tumori Giovanni Paolo II- Bari, Bari, Italy
17Department of Medicine and Surgery, University of Salerno, University of Salerno, Baronissi, Salerno, Italy
18Hematology Unit, Hematology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
19ASSL NUORO, PRESIDIO OSPEDALIERO SAN FRANCESCO, Nuoro, Italy
20AO OSPEDALI RIUNITI MARCHE NORD - OSPEDALE SAN SALVATORE, Pesaro, Italy
21Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy
22Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
23Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy
24ASL Salerno - Presidio Ospedaliero Tortora Pagani, Pagani, Italy
25Azienda Sanitaria dell'Alto Adige, Bolzano, ITA
26Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
27Hematology and Bone Marrow Transplant, Unit San Raffaele Scientific Institute, Milano, Milano, Italy
28Division of Hematology, Azienda Ospedaliera SS Arrigo E Biagio E Cesare Arrigo, Alessandria, ITA
29Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy
30Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
31Hematology and Stem Cell Transplantation Division, European Institute of Oncology, Milan, Italy
32Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy

3:00 PM

Shanshan Suo, MD1*, Ying Lu2*, Wenjuan Yu1*, Chunmei Yang1*, Lijing Shen3*, Renzhi Pei2*, Beiwen Ni3*, Wanzhuo Xie, M.D.1*, Liping Mao, M.D.1*, Xingnong Ye1*, Jiejing Qian1*, Jin Wang, MD, PhD4*, Bingzong Li, MD, PhD5, Xiaomin Wang6*, Linjie Li7*, Dan Zhao8*, Yongming Xia9*, Lihong Shou10*, Yanping Shao11*, Da Gao, MD12*, Wenyuan Mai1*, De Zhou, M.D.1*, Gaixiang Xu1*, Min Yang, M.D.1*, Yinjun Lou, MD, PhD1*, Hongyan Tong, PhD13, Huafeng Wang1* and Jie Jin1

1Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
3Department of Hematology, Renji hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
5Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
6Department of Hematology, the First Hospital of Shanxi Medical University, Taiyuan, China
7Lishui Municipal Central Hospital, Lishui, CHN
8Department of Hematology, Yuncheng Central Hospital, Yuncheng, China
9Department of Hematology, Yuyao People's Hospital of Zhejiang Province, Yuyao, AL, China
10Department of Hematology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, China
11Department of Hematology,Taizhou Hospital Of Zhejiang Province, Taizhou, China
12The affiliated hospital of inner mongolia medical univuniversity, Hohhot, China
13Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

3:15 PM

Nicholas J. Short, MD1, Hagop Kantarjian, MD1, Nitin Jain, MD1, Koichi Takahashi, MD, PhD2, Ken Furudate, DMD, PhD1*, Jayastu Senapati, MD, DM, MBBS1, Fadi G. Haddad, MD1, Omer Karrar3*, Tapan M. Kadia, MD1, Kelly S. Chien, MD4, Koji Sasaki, MD1, Eitan Kugler, MD PhD1*, Rebecca Garris1*, Farhad Ravandi, MBBS5 and Elias Jabbour, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, MD Anderson, Houston, TX
5Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

3:30 PM

Michela Ansuinelli, MD, PhD1*, Maria Stefania De Propris, MD, PhD1*, Maria Cristina Puzzolo, PhD1*, Nadia Peragine, PhD1*, Tiziano Quacquarelli, BS1*, Saveria Capria, MD1*, Cristina Skert, MD2*, Valentina Mancini, MD3*, Simona Sica, MD, PhD4*, Federico Lussana5*, Erika Borlenghi, MD6, Marco Cerrano, MD7*, Daniele Vallisa, MD8*, Valeria Cardinali, MD9*, Sabina Chiaretti, MD, PhD1, Anna Guarini, PhD10* and Robin Foà, MD10*

1Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
2Azienda Ulss3 Serenissima,Hematology Unit, Ospedale dell'Angelo, Venezia, Italy
3Department of Hematology and Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
4Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica Sacro Cuore, Rome, Italy
5Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
6Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
7Division of Hematology, Department of Oncology, A.O.U. Città della Salute e della Scienza di Torino, Torino, To, Italy
8Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy
9Center for Hemato-Oncological Research (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy
10Department of Translational and Precision Medicine, Division of Hematology, Sapienza University, Rome, Italy

3:45 PM

Jieping Lin1*, Chenhao Ding1*, Zicong Huang1*, Cai Zihong1*, Jia Li1*, Zhixiang Wang1*, Xiaofang Li1*, Xuan Zhou1*, Bailin He2*, Wenhao Zhong1*, Li Xuan1*, Qifa Liu, MD2, Yang Xu3* and Hongsheng Zhou1,4,5*

1Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
3The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China
4Guangdong Provincial Clinical Research Center for Hematologic Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
5Department of Hematology, People's Hospital of Ganzhou, Ganzhou, China

4:00 PM

Heike Pfeifer1*, Fabian Lang, MD2*, Walter Fiedler, MD3, Matthias Stelljes, MD4, Folker Schneller, MD5*, Björn Steffen, MD6*, Boris Böll, MD7*, Andreas Viardot, MD, PhD8, Christoph Faul, MD9, Lino L. Teichmann, MD10*, Hendrik Poeck, MD11, Joerg Westermann, MD12, Kerstin Schäfer-Eckart, MD13*, Thomas Heinicke, MD14*, Thomas Burmeister, MD, PhD15*, Stefan Schwartz, MD16*, Monika Brueggemann, PhD17*, Hubert Serve, MD18 and Nicola Goekbuget, MD6

1Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/M., Germany
2Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany
3Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4Department of Medicine A (Hematology, Hemostaseology, Oncology, Pneumology), University of Muenster, Muenster, Germany
5Klinikum Rechts der Isar der TU München, Munich, Germany
6Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany
7Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne; equal contribution, Cologne, Germany
8Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
9Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tübingen, Germany
10Department of Medicine III, University Hospital Bonn, Bonn, Germany
11Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
12Hematology, Oncology and Tumor Immunology, Campus Virchow Klinikum, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, DEU
13Department of Internal Medicine V, Paracelsus University Hospital Nuremberg, Nuremberg, Germany
14Department of Hematology and Oncology, University Hospital Magdeburg, Magdeburg, Sachsen-Anhalt, Germany
15Department of Hematology, Oncology and Cancer Immunology (Campus Virchow Klinikum), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany
16Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany
17University Hospital Schleswig-Holstein, Kiel, DEU
18Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany

*signifies non-member of ASH